,i  #aaf? ,,congress  #b;d ,session  ,h4
 ,r4 #hjfg  ,,9 ,,! ,,h\se ,,(          
,,repres5tatives  ,augu/ #ah1 #bjbj ,mr4
 ,bey] 7= himself1 ,ms4 ,sewell (       
,alabama1 ,ms4 ,roybal-,all>d1 & ,mrs4  
,d+ell7 introduc$ ! foll[+ bill2 :i* 0  
ref]r$ to ! ,committee on ,en]gy &      
,comm]ce  ,a ,,bill  ,to direct !       
,secret>y ( ,heal? & ,human ,s]vices1   
act+ ?r\gh ! ,director ( ! ,ag5cy =     
,heal?c>e ,rese>* & ,quality1 to conduct
 or support rese>* relat$ to ! ,unit$   
,/ates heal? c>e sy/em's response to    
,,covid-#ai1 & = o!r purposes4  #a4     
,%ort title ,?is ,act may be cit$ z !   
,address+ ,,covid-#ai ,heal? ,disp>ities
 ,act4  #b4 ,rese>* on ,unit$ ,/ates    
heal? c>e sy/em's response to           
,,covid-#ai  7a7 ,9 g5]al ,! ,secret>y (
 ,heal? & ,human ,s]vices1 act+ ?r\gh ! 
,director ( ! ,ag5cy = ,heal?c>e ,rese>*
 & ,quality1 %all conduct or support    
rese>* relat$ to ! ,unit$ ,/ates heal?  
c>e sy/em's response to ,,covid-#ai1    
includ+ ) respect to--  7#a7 ! expansion

 & efficacy ( teleheal? use1 includ+--  
7,a7 id5tify+ ob/acles to access =      
vet]ans1 ! eld]ly1 & l[-income          
communities2  7,b7 evaluat+ & id5tify+  
pot5tial gaps or o!r weaknesses t be> on
 racial & e?nic disp>ities 9 ,,covid-#ai
 infection rates1 sev]ity ( symptoms1 & 
outcomes2  7,c7 gaps 9 compliance )     
heal? c>e privacy & security rules2 &   
7,d7 evaluate :e!r access to1 or        
treatm5t associat$ )1 telem$ic9e & c>e  
deliv]$ 9 diff]5t sett+s v>i$ by racial 
& e?nic gr\p2 &  7#b7 conduct+ & support
 rapid turn>\nd rese>* to--  7,a7       
id5tify heal? c>e /rategies t help      
mitigate racial & e?nic disp>ities 9    
,,covid-#ai infection rates1 sev]ity (  
symptoms1 & outcomes2  7,b7 id5tify     
heal? c>e-relat$ factors contribut+ to  
su* disp>ities racial & e?nic disp>ities
 9 ,,covid-#ai infection rates1         
hospitalizations1 sev]ity ( disease1    
complications1 & outcomes2  7,c7 provide
 recomm5dations on ensur+ equity 9      
access to o!r heal? c>e int]v5tions1 su*

 z flu & pneumococcal pneumonia         
vacc9ation1 t may be advanc$ to mitigate
 su* disp>ities1 go+ =w>d2  7,d7 id5tify
 defici5cies 9 ! heal? c>e sy/em's      
supply *a92 &  7,e7 %ortfalls 9 ! heal? 
c>e deliv]y plann+1 coord9ation1 &      
capacity1 includ+ heal? c>e deliv]y to  
vuln]able communities4  7b7 ,protocols  
on ,,covid-#ai disp>ities ,! ,secret>y (
 ,heal? & ,human ,s]vices1 act+ ?r\gh ! 
,director ( ! ,ag5cy = ,heal?c>e ,rese>*
 & ,quality1 %all coord9ate cross-ag5cy 
engagem5t ) lead]s f racial & e?nic     
m9ority gr\ps & o!r populations         
disproportionately affect$ by           
,,covid-#ai--  7#a7 to develop protocols
 t ensure ^! gr\ps h timely access to   
safe & effective ,,covid-#ai vacc9es2 & 
7#b7 to provide guidance on a           
,,covid-#ai vacc9ation /rategy t takes  
into acc\nt racial & e?nic disp>ities 9 
,,covid-#ai infection rates1 sev]ity (  
symptoms1 & heal? outcomes4  7c7        
,au?orization ( appropriations ,!re is  
au?oriz$ to be appropriat$ to c>ry out  

?is section #aba1jjj1jjj1 to rema9      
available until exp5d$4